ArticleNature communications2024

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria.

Stian Foss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.